Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/21567

Title: Neratinib after trastuzumab in patients with HER2-positive breast cancer Reply
Authors: Chan, Arlene
Buyse, Marc
Yao, Bin
Issue Date: 2016
Citation: LANCET ONCOLOGY, 17 (5), p. E176-E177
Notes: [Chan, Arlene] Breast Canc Res Ctr Western Australia, Perth, WA, Australia. [Buyse, Marc] Int Inst Drug Dev, San Francisco, CA USA. [Buyse, Marc] Hasselt Univ, I BioStat, Hasselt, Belgium. [Yao, Bin] Puma Biotechnol Inc, Los Angeles, CA USA.
URI: http://hdl.handle.net/1942/21567
ISI #: 000374829800006
ISSN: 1470-2045
Category: A1
Type: Journal Contribution
Validation: ecoom, 2017
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
published version144.07 kBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.